Drug Trial Radar · NCT01518699
Study to Evaluate the Effect of Ha44 Gel on the Electrocardiogram in Healthy Volunteers
Last checked: Nov 20, 2026Latest source record: Jul 9, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
57
Actual
Start
Jan 2012
Primary completion
May 2012
Study completion May 2012
Sponsor
- Lead sponsor
- Dr. Reddy's Laboratories Limited, IndiaIndustry
- Sponsor type
- Industry
- First posted
- Jan 26, 2012
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 50 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to Evaluate the Effect of Ha44 Gel on the Electrocardiogram in Healthy Volunteers.
Conditions
- Pediculosis
Interventions
Ha44Drug
Abametapir Lotion 0.74%
Ha44 PlaceboDrug
Ha44 Vehicle Gel without Abametapir
Moxifloxacin PlaceboDrug
Moxifloxacin Placebo
MoxifloxacinDrug
Moxifloxacin 400mg
Primary outcomes
What the sponsor says the trial is designed to measure.
- Difference Between Active and Placebo for Time Matched Baseline Adjusted Mean QTcFTime frame: 36 hours
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Spaulding Clinical
West Bend, Wisconsin
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.